Welcome to the National Institute for Health and Clinical Excellence
NICE is an independent organisation responsible for providing national guidance on promoting good health and preventing and treating ill health.
Using guidance
NICE helps health professionals implement our guidance by providing tools such as cost templates, audit criteria and slide sets.
Get involved
-
Prevention of ventilator-associated pneumonia additional assessment (second consultation)
-
Head and neck cancer - cetuximab (final appraisal determination)
-
Rheumatoid arthritis - adalimumab, etanercept and infliximab (sequential use): (appraisal consultation document)
Latest guidance
-
Colitis (ulcerative) - infliximab
-
Perioperative hypothermia (inadvertent)
-
Rheumatoid arthritis (refractory) - abatacept
-
Interstitial photodynamic therapy for malignant parotid tumours
In focus
NICE 2008: highlights, including the Shared Learning Awards
Latest news
-
NICE responds to Court of Appeal's ruling on Alzheimer's appraisal
1 May 2008
-
NICE guidance aims to prevent hypothermia in patients undergoing surgery
23 Apr 2008
-
NICE is looking for patient/carer members of the development group looking at rehabilitation for people with a critical illness
16 Apr 2008
